Healx
Updates
News
Latest news posts
3 December 2024
Jonathan Milner, Ph.D., Appointed as Non-Executive Chairman of Healx
Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced the appointment of Jonathan Milner, Ph.D., as the new non-executive chairman of the board, effective immediately. This transition comes as current chairman and co-founder David Brown, Ph.D., begins a secondment to pursue academic research at Trinity College, Cambridge University. While pursuing his studies, … Continued
13 November 2024
Healx announces agreement with Sanofi to seek new rare disease indications for compound using AI drug discovery platform
Cambridge, UK, November 13, 2024 –Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced it will use a Sanofi compound to identify new disease indications using Healnet, Healx’s AI-driven drug discovery platform. Under the agreement, Sanofi will provide data related to a late stage discontinued asset that is being considered for out-licensing. … Continued
Awards
Best Use of AI in Health and Medicine 2019
AI Company of the Year 2019
Future Fifty 8.0 Cohort
Company Award for Innovation 2020
Outstanding Achievement in Social Good Use of AI 2020
Outstanding AI Accelerator 2020
Best AI Product in Health 2020
CB Insights Digital Health 150 2020
East of England Tech 50
Top 50 Companies to Work for 2021
Top Biotech R&D Tech Startups 2020
Tech for Good Award 2021
Top Life Sciences Platform Startups 2021
Outstanding Achievement in Social Good use of AI 2021
Tech4Good Awards: AI for Good winner
London Tech Week: Tech for Impact Startup of the Year (Shortlisted)
Eurordis Black Pearl Award
Life Sciences AI Awards 2024